Debra Nathan

Title: Debra Nathan: Innovator in Pharmaceutical Assays

Introduction

Debra Nathan is a prominent inventor based in Mt. Kisco, NY (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative assays for drug screening. Her work focuses on enhancing the efficiency of identifying compounds that interact with cellular proteins.

Latest Patents

Debra Nathan holds a patent for "Recombinant yeast cells for identifying receptor effectors." This invention provides a rapid and effective assay for screening and identifying pharmaceutically effective compounds that specifically interact with and modulate the activity of cellular proteins, such as receptors or ion channels. The assay enables the rapid screening of large numbers of compounds to identify those that act as agonists or antagonists to the bioactivity of the cellular protein. It is particularly useful for identifying surrogate ligands for receptors from small molecule or peptide libraries or from peptides produced by an autocrine system. She has 1 patent to her name.

Career Highlights

Debra Nathan has established herself as a key figure in the pharmaceutical industry. She works at Cadus Pharmaceutical Corporation, where her expertise in assay development is highly valued. Her innovative approach has contributed to advancements in drug discovery processes.

Collaborations

Debra collaborates with notable colleagues, including Joshua Trueheart and Jeremy I Paul. These partnerships enhance her research and development efforts, leading to more effective pharmaceutical solutions.

Conclusion

Debra Nathan's work in developing innovative assays for drug screening exemplifies her commitment to advancing pharmaceutical research. Her contributions are paving the way for more efficient drug discovery processes, ultimately benefiting the healthcare industry.